ExeVir Bio: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ExeVir Bio
Largest movements
- Cash -€2.3m
down €2.3m (-71.0%), from €3.2m to €925,562
mainly Net result for the year (-€1.9m) and Trade debts (-€600,252)
- Receivables after one year -€383,967
down €383,967 (-14.3%), from €2.7m to €2.3m
- Intangible fixed assets -€303,362
down €303,362 (-99.9%), from €303,544 to €182
- Receivables within one year +€281,809
up €281,809 (+193.0%), from €146,019 to €427,827
of which Other amounts receivable: +€295,273
- Tangible fixed assets -€72,465
down €72,465 (-46.7%), from €155,262 to €82,797
of which Plant, machinery and equipment: -€69,317
- Profit (loss) carried forward -€1.9m
down €1.9m (-19.3%), from -€10.1m to -€12.0m
- Trade debts -€600,252
down €600,252 (-91.8%), from €653,700 to €53,447
- Other debts -€127,921
down €127,921 (-100.0%), from €127,921 to €0
- Tax, wage and social debts -€101,391
down €101,391 (-99.9%), from €101,525 to €134
of which Remuneration and social security: -€101,524
- Depreciation -€4.3m
down €4.3m (-92.6%), from €4.7m to €344,636
- Gross operating margin -€2.1m
down €2.1m, from €939,421 to -€1.2m
- Staff costs -€906,523
down €906,523 (-68.8%), from €1.3m to €411,091
- Taxes +€184,088
up €184,088 (+90.6%), from -€203,239 to -€19,151
- Financial income -€113,065
down €113,065 (-86.6%), from €130,552 to €17,487
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,532,585 | €3,758,508 | -€2.8m | -42.5% |
| Fixed assets | 21/28 | €480,264 | €97,089 | -€383,175 | -79.8% |
| Intangible fixed assets | 21 | €303,544 | €182 | -€303,362 | -99.9% |
| Tangible fixed assets | 22/27 | €155,262 | €82,797 | -€72,465 | -46.7% |
| Plant, machinery and equipment | 23 | €151,637 | €82,320 | -€69,317 | -45.7% |
| Furniture and vehicles | 24 | €3,624 | €477 | -€3,147 | -86.8% |
| Financial fixed assets | 28 | €21,458 | €14,110 | -€7,349 | -34.2% |
| Current assets | 29/58 | €6,052,321 | €3,661,419 | -€2.4m | -39.5% |
| Amounts receivable after more than one year | 29 | €2,682,521 | €2,298,555 | -€383,967 | -14.3% |
| Other amounts receivable | 291 | €2,682,521 | €2,298,555 | -€383,967 | -14.3% |
| Amounts receivable within one year | 40/41 | €146,019 | €427,827 | +€281,809 | +193.0% |
| Trade receivables | 40 | €13,465 | €0 | -€13,465 | -100.0% |
| Other amounts receivable | 41 | €132,554 | €427,827 | +€295,273 | +222.8% |
| Current investments | 50/53 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €3,191,055 | €925,562 | -€2.3m | -71.0% |
| Deferred charges and accrued income | 490/1 | €32,725 | €9,474 | -€23,251 | -71.0% |
| Total equity and liabilities | 10/49 | €6,532,585 | €3,758,508 | -€2.8m | -42.5% |
| Equity | 10/15 | €5,616,541 | €3,672,552 | -€1.9m | -34.6% |
| Contributions | 10/11 | €15,700,791 | €15,700,791 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€10,084,250 | -€12,028,240 | -€1.9m | -19.3% |
| Amounts payable | 17/49 | €916,044 | €85,956 | -€830,088 | -90.6% |
| Amounts payable within one year | 42/48 | €915,520 | €85,956 | -€829,564 | -90.6% |
| Current portion of amounts payable after more than one year | 42 | €32,375 | €32,375 | = | 0.0% |
| Trade debts | 44 | €653,700 | €53,447 | -€600,252 | -91.8% |
| Suppliers | 440/4 | €653,700 | €53,447 | -€600,252 | -91.8% |
| Taxes, remuneration and social security | 45 | €101,525 | €134 | -€101,391 | -99.9% |
| Taxes | 450/3 | €1 | €134 | +€133 | +11764.6% |
| Remuneration and social security | 454/9 | €101,524 | €0 | -€101,524 | -100.0% |
| Other amounts payable | 47/48 | €127,921 | €0 | -€127,921 | -100.0% |
| Accrued charges and deferred income | 492/3 | €523 | €0 | -€523 | -100.0% |
| Remuneration, social security and pensions | 62 | €1,317,614 | €411,091 | -€906,523 | -68.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,677,558 | €344,636 | -€4.3m | -92.6% |
| Other operating charges | 640/8 | €78,680 | €46,355 | -€32,325 | -41.1% |
| Gross operating margin | 9900 | €939,421 | -€1,174,457 | -€2.1m | |
| Operating profit (loss) | 9901 | -€5,134,431 | -€1,976,539 | +€3.2m | +61.5% |
| Financial income | 75/76B | €130,552 | €17,487 | -€113,065 | -86.6% |
| Recurring financial income | 75 | €130,552 | €17,487 | -€113,065 | -86.6% |
| Financial charges | 65/66B | €22,281 | €4,088 | -€18,193 | -81.7% |
| Recurring financial charges | 65 | €22,281 | €4,088 | -€18,193 | -81.7% |
| Profit (loss) for the period before taxes | 9903 | -€5,026,160 | -€1,963,140 | +€3.1m | +60.9% |
| Income taxes | 67/77 | -€203,239 | -€19,151 | +€184,088 | +90.6% |
| Profit (loss) for the period | 9904 | -€4,822,921 | -€1,943,989 | +€2.9m | +59.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€4,822,921 | -€1,943,989 | +€2.9m | +59.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.